Anti-Tau Therapeutic Antibody, E2814, Reduces Early and Late Tau Pathology Biomarkers in Patients with Dominantly-Inherited Alzheimer’s Disease (DIAD)
Wildsmith CTAD Presentation
Anti-Tau Therapeutic Antibody, E2814, Reduces Early and Late Tau Pathology Biomarkers in Patients with Dominantly-Inherited Alzheimer’s Disease (DIAD)
